Adverse effects of novel immunotherapies appear controllable compared with chemotherapy in hematologic malignancies, according to Guenther Koehne, MD.
Guenther Koehne, MD
Advertisement
Articles by Guenther Koehne, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Enolen Displays 84% Reduction in Tumor Volume of Localized Prostate Cancer
2
Navigating Oligometastasis and Oligoprogression in Stage IV Breast Cancer
3
FDA Receives NDA Resubmission for 18F-FET PET Imaging Agent in Recurrent Glioma
4
Investigators to Discontinue Trial of Eftilagimod Alfa in Frontline NSCLC
5